Cargando…

Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy

The concept of diabetic retinopathy (DR) has been extended from microvascular disease to neurovascular disease in which microglia activation plays a remarkable role. Fractalkine (FKN)/CX3CR1 is reported to regulate microglia activation in central nervous system diseases. To characterize the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Mengmeng, Xie, Hai, Zhang, Chaoyang, Wang, Tianqin, Tian, Haibin, Lu, Lixia, Xu, Jing‐Ying, Xu, Guo‐Tong, Liu, Lin, Zhang, Jingfa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831940/ https://www.ncbi.nlm.nih.gov/pubmed/35023309 http://dx.doi.org/10.1111/jcmm.17179

Ejemplares similares

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)

Fractalkine/CX3CR1 signaling during neuropathic pain
por: Clark, Anna K., et al.
Publicado: (2014)

Fractalkine/CX(3)CR(1) Pathway in Neuropathic Pain: An Update
por: Silva, Rita, et al.
Publicado: (2021)

EHMTI-0062. Expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the trigeminal ganglia: implications for craniofacial nociception
por: Gazerani, P, et al.
Publicado: (2014)

Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling
por: Briones, Teresita L, et al.
Publicado: (2014)

Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis
por: Celesti, G, et al.
Publicado: (2013)

Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling
por: Roche, Sarah L., et al.
Publicado: (2016)

Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina
por: Roche, Sarah L., et al.
Publicado: (2017)

Association of CX3CR1 Gene Polymorphisms with Fractalkine, Fractalkine Receptor, and C-Reactive Protein Levels in Patients with Kidney Failure
por: Woźny, Łukasz, et al.
Publicado: (2021)

Retraction Note: Chronic neuroinflammation and cognitive impairment following transient global cerebral ischemia: role of fractalkine/CX3CR1 signaling
por: Briones, Teresita L., et al.
Publicado: (2015)

Melatonin Maintains Inner Blood–Retinal Barrier by Regulating Microglia via Inhibition of PI3K/Akt/Stat3/NF-κB Signaling Pathways in Experimental Diabetic Retinopathy
por: Tang, Lei, et al.
Publicado: (2022)

The Chemokine CX3CL1 (Fractalkine) and its Receptor CX3CR1: Occurrence and Potential Role in Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2014)

Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway
por: Imai, Toshio, et al.
Publicado: (2016)

Fractalkine Signalling (CX(3)CL1/CX(3)CR1 Axis) as an Emerging Target in Coronary Artery Disease
por: Loh, Shu Xian, et al.
Publicado: (2023)

Fractalkine/CX3CR1 Contributes to Endometriosis-Induced Neuropathic Pain and Mechanical Hypersensitivity in Rats
por: Liu, Zhiming, et al.
Publicado: (2018)

Fractalkine receptor chemokine (CX3CR1) influences on cervical and lumbar disc herniation
por: Oh, In-Soo, et al.
Publicado: (2015)

Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease
por: Camacho-Hernández, N. P., et al.
Publicado: (2023)

Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
por: Szukiewicz, Dariusz, et al.
Publicado: (2013)

Polymorphism of the Fractalkine Receptor CX3CR1 and Systemic Sclerosis-associated Pulmonary Arterial Hypertension
por: Marasini, Bianca, et al.
Publicado: (2005)

Fractalkine receptor (CX(3)CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide
por: Corona, Angela W, et al.
Publicado: (2010)

Neuron–glia crosstalk in health and disease: fractalkine and CX(3)CR1 take centre stage
por: Sheridan, Graham K., et al.
Publicado: (2013)

Fractalkine/CX(3)CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?
por: Jeyalan, Visvesh, et al.
Publicado: (2023)

Role of Fractalkine/CX3CR1 Interaction in Light-Induced Photoreceptor Degeneration through Regulating Retinal Microglial Activation and Migration
por: Zhang, Meng, et al.
Publicado: (2012)

Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?
por: Cormican, Sarah, et al.
Publicado: (2021)

Fractalkine/CX3CL1 in Neoplastic Processes
por: Korbecki, Jan, et al.
Publicado: (2020)

Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1
por: Stolla, Moritz, et al.
Publicado: (2012)

Reduced brain fractalkine-CX3CR1 signaling is involved in the impaired cognition of streptozotocin-treated mice
por: Kawamura, Namiko, et al.
Publicado: (2020)

The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival
por: Kuboi, Yoshikazu, et al.
Publicado: (2022)

Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain
por: Zhu, Wenjun, et al.
Publicado: (2013)

Corrigendum to “Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis”
por: Wojdasiewicz, Piotr, et al.
Publicado: (2020)

Fractalkine Signaling Attenuates Perivascular Clustering of Microglia and Fibrinogen Leakage during Systemic Inflammation in Mouse Models of Diabetic Retinopathy
por: Mendiola, Andrew S., et al.
Publicado: (2017)

Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH
por: Chen, Xionghui, et al.
Publicado: (2023)

Neuroinflammation and fractalkine signaling in Alzheimer’s disease
por: Finneran, Dylan J., et al.
Publicado: (2019)

Microglia, seen from the CX(3)CR1 angle
por: Wolf, Yochai, et al.
Publicado: (2013)

Two Polymorphisms in the Fractalkine Receptor CX3CR1 Gene Influence the Development of Atherosclerosis: A Meta-Analysis
por: Wu, Jian, et al.
Publicado: (2014)

Impaired brain fractalkine-CX3CR1 signaling is implicated in cognitive dysfunction in diet-induced obese mice
por: Kawamura, Namiko, et al.
Publicado: (2021)

CX(3)CL1 (fractalkine) and CX(3)CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin
por: Sunnemark, Dan, et al.
Publicado: (2005)

CX(3)CL1 (fractalkine) and its receptor CX(3)CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin
por: Staumont-Sallé, Delphine, et al.
Publicado: (2014)

Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient
por: Siddiqui, Imran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_efsdqn316uet5g5o3q0htip4mm